Alexion Pharmaceuticals
Rebecca Einhorn is an experienced communications leader with a strong background in strategic engagement and external communications. Currently serving as Senior Director of Executive Communications and Strategy at Alexion Pharmaceuticals, Inc. since October 2022, Rebecca has previously held senior roles such as Senior Director of Strategic Engagement at Teladoc Health and Director positions at AstraZeneca, where responsibilities included managing communications during a significant acquisition and promoting advancements in oncology. Rebecca also has extensive experience in public affairs through roles at the United Nations Foundation and Venn Strategies, alongside a foundational career in governmental communications with the U.S. House of Representatives and the Congressional Hispanic Caucus Institute. A graduate of Brandeis University with a BA in American Studies and Spanish Language & Literature, Rebecca’s work has spanned critical industries, focusing on enhancing brand awareness and stakeholder engagement.
This person is not in any teams
This person is not in any offices
Alexion Pharmaceuticals
44 followers
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which is engaged in the discovery, development and commercialization of biologic therapeutic products aimed at treating patients with severe and life-threatening disease states, including hematologic, kidney and neurologic diseases, transplant rejection, cancer and autoimmune disorders.